Betulin was converted to the corresponding alkyne-functionalized esters and amides and subsequently deployed as substrates for a 'click' chemistry-mediated coupling with 3'-azido-3'-deoxythydimine (AZT) to furnish a novel betulin-triazole-AZT hybrid compounds. Eleven new hybrids were thus successfully prepared and evaluated as cytotoxic agents, revealing an interesting anticancer activity in KB and HepG2 cancer cell lines. [8] [9] , and antitumor activities against various types of cancer cell lines [10] [11] [12] [13] [14] . Betulin has been also known as an interesting scaffold for accessing derivatives displaying various biological properties. To improve the biological potency of betulin, its esters or amides at C-3 and/or C-28 were prepared, which showed promising cell proliferative inhibition significantly [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . Furthermore, here the 28-O-acyl group is also being used as a linker in the conjugates of betulin and its derivatives with different bioactive entities, in particular 3'-azido-3'-deoxythymidine (AZT), to obtain anti-HIV hybrid conjugates with potent activities [17] [18] [19] [20] . On the other hand, previous works already indicated that the introduction of triazoyl group to pentacyclic triterpenoids could result in good biological activities [21] [22] [23] [24] [25] [26] [27] . 'Click' chemistry provides an easy and productive way for linking two molecules, even when one of them is a large natural product. Using a triazole linkage to link AZT with betulin/betulinic acid, several hybrid compounds was designed and achieved as potential anti-HIV agents [21] as well as cancer cell inhibitors [22, 23] .
Betulin is an abundant and naturally occurring pentacyclic triterpenoid [1] [2] , which possesses broad-spectrum biological and pharmacological activities, including anti-HIV [3] , antiinflammatory [4] [5] , antiretroviral [6] , antibacterial [7] , anticancer [8] [9] , and antitumor activities against various types of cancer cell lines [10] [11] [12] [13] [14] . Betulin has been also known as an interesting scaffold for accessing derivatives displaying various biological properties. To improve the biological potency of betulin, its esters or amides at C-3 and/or C-28 were prepared, which showed promising cell proliferative inhibition significantly [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . Furthermore, here the 28-O-acyl group is also being used as a linker in the conjugates of betulin and its derivatives with different bioactive entities, in particular 3'-azido-3'-deoxythymidine (AZT), to obtain anti-HIV hybrid conjugates with potent activities [17] [18] [19] [20] . On the other hand, previous works already indicated that the introduction of triazoyl group to pentacyclic triterpenoids could result in good biological activities [21] [22] [23] [24] [25] [26] [27] . 'Click' chemistry provides an easy and productive way for linking two molecules, even when one of them is a large natural product. Using a triazole linkage to link AZT with betulin/betulinic acid, several hybrid compounds was designed and achieved as potential anti-HIV agents [21] as well as cancer cell inhibitors [22, 23] .
Thus, in view of the previous rationale and in continuation of our ongoing research on the pharmacophore hybridization of lupane triterpenoid acid derivatives [20, 22, 23] , herein, we report the research on conjugation of AZT with 28-O-acylbetulin derivatives by 'click' chemistry. The anticancer activity evaluation results revealed that the triazole-betulin-AZT hybrids exhibited potent anticancer activity.
For this purpose, the ester-triazole-linked betulin-AZT hybrids 11a-f were synthesized following the synthetic procedure illustrated in Scheme 1. Acid anhydrides were introduced at the C-28 position in dichloromethane in the presence of triethylamine at room temperature for 12 h to gain betulin acids 9a-f. Compounds 9a-f were esterified with propargyl bromide to afford acetylene-functionalized esters 10a-f, which subsequently hybridized with AZT using CuI in t-BuOH at 70 o C to obtain the target hybrids 11a-f in high yields (63-91 %). Analogously, amide triazole-linked betulin-AZT conjugates 13a-e were obtained via the synthetic procedure shown in Scheme 2 using amide-containing betulin as coupling partners. The acids 9a-e were reacted with propargyl amine in dimethylformamide in the presence of HOBt/DCC/DIPEA to generate amides 12a-e, which then were subjected to a 'click' chemistry-mediated coupling with AZT to furnish target conjugates 13a-e in good yields (56-78 %). All the compounds were fully characterized by various spectroscopic methods.
The newly prepared compounds were subjected to in vitro biological assessment against two human cancer cell lines (KB-CCL-17, HepG2-HB-8065), and the results are summarized in Table 1 . These results indicated that most of the derivatives possess at least moderate cytotoxic activity, and several triazole-betulin-AZT conjugates even display a promising activity profile. It is important to note that the starting betulin acids 9a-f and AZT display considerably less potent cytotoxic activities (IC 50 values ranging from 60 to > 150 µM) as compared to the most promising conjugates 11c-f (IC 50 < 10 µM) showing a reasonable activity against both cancer cells.
The ester-triazole-linked betulin-AZT hybrid compounds 11a-f show potent cytotoxicity against KB (IC 50 < 9 µM) and HepG2 (IC 50 < 15 µM) cell lines. Especially, hybrid 11f can be identified as the most promising compound with IC 50 values below 1.5 µM against both KB and HepG2 cell lines (0.38 and 1.32 µM, respectively), thus representing a suitable template for further elaboration and optimization toward potent cytotoxic agents. These biological results clearly demonstrate the added value of merging AZT and 28-O-acylbetulin into single hybrid compounds using ester-triazole linkage in terms of their anticancer properties. On the other hand, compared of the cytotoxicity of amide-triazole-linked betulin-AZT hybrids with the ester-linked counterparts, it is clear that the nitrogen analogs (hybrids 13a-e) exhibit less potent cytotoxic effects than corresponding oxygen counterparts (hybrids 11a-e).
In conclusion, 'click' chemistry techniques were applied to obtain new triazole-betulin-AZT hybrid compounds starting from the naturally occurring triterpene betulin. The methods presented in this work allowed the synthesis of eleven new compounds in reasonable to good yields. The compounds were assessed as anticancer agents in two human cancer cell lines KB and HepG2. The biological results indicated that the ester-triazole-linked betulin-AZT hybrids displayed a promising potential for further elaboration toward novel anticancer agents, meanwhile the amide-triazole-linked analogs are much less active. The parent pharmacophores also showed considerably less potent cytotoxic activities as compared to the most promising conjugates, pointing to the added value of merging AZT and 28-O-acylbetulins into single hybrid compounds in terms of their anti-proliferative activity.
Experimental
General: All reactions were performed in the appropriate ovendried glass apparatus and under air atmosphere. Unless otherwise stated, solvents and chemicals were obtained from commercial sources and used without further purification. Column chromatography was performed using silica gel (60 Å, particle size 40-60 µm). NMR spectra were recorded on a Bruker Avance (500 MHz). Chemical shifts (δ) are given in parts per million (ppm) and coupling constants (J) in hertz (Hz). High resolution mass spectrometry analysis (HRMS) was recorded on a Q-exactive or a Q-TOF2 instrument. IR analysis was recorded on Perkin Elmer Spectrum Two.
Preparation of compounds 9a-f:
A solution of betulin 1 (5 mmol) and Et 3 N (6 mmol) in dichloromethane (20 ml) was stirred at room temperature for 15 min. Acid anhydrides (20 mmol) was then added and the resulting mixture was stirred at room temperature for 12 h. Afterwards, the solvent was removed in vacuo, and the residue was redissolved in EtOAc (20 mL) and washed with water (20 mL). The aqueous phase was extracted with EtOAc (20 ml x 3). Drying (Na 2 SO 4 ), filtration of the drying agent, and removal of the solvent in vacuo afforded 28-O-acylbetulins 9a-f, which were further purified by means of column chromatography on silica gel using nhexane/ethyl acetate.
Preparation of compounds 10a-f:
Compound 9a-f (2 mmol) and Cs 2 CO 3 (4 mmol) were dissolved in 10 ml DMF/ THF (1:1), and stirred for 30 min at room temperature. Propagyl bromide (4 mmol) was then added, and the reaction was carried out for 4-6 h at room temperature. The reaction mass was extracted with EtOAc (20 ml x 3), the combined organic phases dried with Na 2 SO 4 , and evaporated in vacuo. The residue was further purified by column chromatography on silica gel to obtain pure compounds 10a-f.
Preparation of compound 12a-e:
To a solution of compound 9a-e (1.0 mmol), N,N'-dicyclohexylcarbodiimide DCC (1.5 mmol), hydroxybenzotriazole HOBt (1.5 mmol) and N,N-diisopropylethylamine DIPEA (2.0 mmol) in DMF (5 ml) and the mixture was stirred for 30 min at room temperature. Afterwards, propagyl amine (1.5 mmol) was added and reaction was carried out at room temperature for 12 h. The reaction mixture was quenched with water (10 mL), extracted with EtOAC (3 × 10 mL). Drying (Na 2 SO 4 ), filtration of the drying agent, and evaporation of the solvent afforded crude products 12a-e, which were purified by silica gel column chromatography using n-hexane/EtOAc as an eluent.
Preparation of hybrid compounds 11a-f, 13a-e:
Compound 10a-f (1.0 mmol) or 12a-e (1.0 mmol) was added to a solution of AZT (0.7 mmol) and CuI (0.1 mmol) in t-BuOH (20 mL). After stirring and heating at 70 o C for 12 h, the reaction mixture was poured into water (10 mL), extracted with EtOAC (3 × 10 mL). Drying (Na 2 SO 4 ), filtration of the drying agent, and evaporation of the Synthesis and cytotoxic evaluation of betulin-triazole-AZT hybrids Natural Product Communications Vol. 12 (10) 2017 1569 solvent afforded crude products, which were purified by means of column chromatography purification on silica gel using n-hexane/EtOAc as an eluent. 1R,3aS,5aR,5bR,9S,11aR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysen3a-yl)methyl 6-(2-(1-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)acetyl)cyclohex-3-ene-1 1R,3aS,5aR,5bR,9S,11aR)-9-hydroxy-5a,5b,8,8,11a- 1R,3aS,5aR,5bR,9S,11aR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysen3a-yl)methyl 4-(((1-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl) Supplementary data: Experimental details and the characterization data associated with this article can be found in the online version.
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